Enhancement by perflusion emulsion (oxygent) and carbogen breathing of the tumor growth delay of the fsaiic fibrosarcoma after treatment with antitumor alkylating agents

Biomaterials, Artificial Cells and Immobilization Biotechnology

Volumn 20, Issue 4 --Feb, 1992, Pages 895-898

  Holden, Sylvia A ^a   Teicher, Beverly A ^a   Ha, Chul ^a   Ara, Gulshan ^a   Herman, Terence S ^a  

^a HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; DRUG THERAPY; EMULSIONS; FLUOROCARBONS; MASS TRANSFER; ONCOLOGY; OXYGEN;

ANTITUMOR ALKYLATING AGENTS; CANCER THERAPY ADJUVANTS; CHEMOTHERAPEUTIC AGENTS; CHEMOTHERAPY ENHANCEMENT; FLUOROCARBON-BASED BLOOD SUBSTITUTES; HYPOXIC TUMOR CELL OXYGENATION; PERFLUOROCHEMICAL EMULSIONS; PERFLUOROOCTYLBROMIDE EMULSIONS; SYNERGISTIC EFFECTS;

BLOOD SUBSTITUTES;

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CARBOGEN; CARBON DIOXIDE; CYCLOPHOSPHAMIDE; FLUOSOL DA; MELPHALAN; OXYGEN; PERFLUORO COMPOUND; PERFLUOROOCTYL BROMIDE;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER; CANCER GROWTH; CANCER INHIBITION; CONFERENCE PAPER; EMULSION; FIBROSARCOMA; HYPOXIC CELL; MOUSE; NONHUMAN; OXYGEN BREATHING; PHARMACEUTICS; TUMOR MODEL;

ALKYLATING AGENTS; ANIMAL; BLOOD SUBSTITUTES; CARBON DIOXIDE; COMBINED MODALITY THERAPY; EMULSIONS; FLUOROCARBONS; MALE; MICE; MICE, INBRED C3H; OXYGEN; SARCOMA, EXPERIMENTAL; SUPPORT, NON-U.S. GOV'T;

EID: 0026616256     PISSN: 10557172     EISSN: None     Source Type: Journal    
DOI: 10.3109/10731199209119736     Document Type: Article

References (19)

1. Kennedy. K. A. Teicher, B. A. Rockwell, S. A. et al. Biochem. Pharmacol. 29:1-8, 1980.
2. Kennedy, K. A. Teicher, B. A. Rockwell, S. C. et al. In: A. C. Sartorelli, J. S. Lazo and J. R. Bertino (eds.), Molecular Actions and Targets for Cancer Chemotherapeutic Agents, Bristol-Meyers Cancer Symposia, Vol. 2, pp. 85-101. New York: Academic Press, 1981.
3. Teicher. B. A. Lazo. J. S. and Sartorelli A. C. Cancer Res. 41:73-81, 1981.
4. Teicher. B. A. and Sartorelli, A. C. In: I. J. Fidler, R. K. White (eds.). Design of Models for Screening of Therapeutic Agents for Cancer, pp. 19-37. New York: Van Nostrand, 1981.
5. Bush, R. S. and Hill, R. P. Laryngoscope, 85:1119-1133. 1975.
6. Duncan. W. Br. Med. Bull. 29:33-38, 1973.
7. Fowler, J. R. Thomlinson, R. H. and Howes, A. E. Eur. J. Cancer, 6:207-221. 1970.8.
8. Sartorelli, A C. Cancer Res. 48:775-778, 1988.
9. Van Putten. L. M. and Kallman R. F. J. Natl. Cancer Inst. 40:441-451, 1968.
10. Teicher, B. A. Holden, S. A. Al-Achl, A. and Herman, T. S. Cancer Res. 50:3339-3344, 1990.
11. Teicher, B. A. Mclntosh-Lowe, N. L. and Rose, C. M. Biomat. Art. Cells Art. Organs. 16:533-546, 1988.
12. Teicher, B. A. and Holden, S. A. Cancer Treat. Rep. 71:173-177. 1987.
13. Teicher, B. A. Herman, T. S. Holden, S. A. and Cathcart. K. N. S. Cancer Chemother. Pharmacol. 21:286-291. 1988.
14. Teicher, B. A. Waxman, D. J. Holden, S. A. Wang, Y. Clarke. L. Alvarez Sotomayor, E. Jones. S. M. and Frei. E. Ill Cancer Res. 49:4996-5001, 1989.
15. Teicher, B. A., Holden, S. A. and Rose, C. M. Int. J. Cancer, 38:285-288. 1986.
16. Teicher. B. A. Herman, T. S. and Rose. C. M. Int. J. Radiat. Oncol. Biol. Phys. 25:1187-1192, 1988.
17. Teicher, B. A. Holden, S. A. and Rose, C. M. Int. J. Cancer, 36:585-589. 1985.
18. Teicher, B. A. Holden, S. A. and Jacobs, J. L. Cancer Res. 47:513-518. 1987.
19. Teicher, B. A. Crawford, J. M. Holden, S. A. and Cathcart, K. N. S. Cancer Res. 47; 5036-5041, 1987.